Inappropriate arrhythmia detection in implantable defibrillator therapy due to oversensing of diaphragmatic myopotentials

• Published in: Journal of interventional cardiac electrophysiology 2001-12, Vol.5 (4), p.487-493
• Main Authors: SCHULTE, Britta, SPERZEL, Johannes, CARLSSON, Jörg, DÜRSCH, Martin, ERDOGAN, Ali, PITSCHNER, Heinz Friedrich, NEUZNER, Jörg
• Format: Article
• Language: English
• Subjects: Adult; Aged; Arrhythmias, Cardiac - diagnosis; Arrhythmias, Cardiac - diagnostic imaging; Arrhythmias, Cardiac - therapy; Biological and medical sciences; Cardiac dysrhythmias; Cardiology. Vascular system; Defibrillators, Implantable - adverse effects; Diaphragm - physiopathology; Electrocardiography; Equipment Failure; Evoked Potentials, Motor - physiology; Female; Follow-Up Studies; Germany - epidemiology; Heart; Humans; Incidence; Male; Medical sciences; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiography; Sensitivity and Specificity; Valsalva Maneuver - physiology
• ISSN: 1383-875X; 1572-8595
• DOI: 10.1023/A:1013214516002

Nonadequate arrhythmia detection and delivery of electrical therapy is still a main problem in current implantable cardioverter defibrillator therapy. Besides supraventricular arrhythmias extra-cardiac biosignals also can cause inadequate shock delivery. The present study focuses on nonadequate arrhythmia detection due to oversensing of diaphragmatic myopotentials. Their clinical characteristics, incidence and management are presented. Three-hundred-eighty-four recipients of a transvenous cardioverter-defibrillator who were implanted and followed-up at our institution between October 1991 and June 1999 were enrolled. During a mean follow-up of 32+/-25 months a total number of 139 nonadequate episodes of arrhythmia detection due to oversensing of diaphragmatic myopotentials were observed in 33 patients (8.6%). In 11 patients a total of 32 high energy shock deliveries occurred. Oversensing of diaphragmatic myopotentials was primarily observed in patients implanted with defibrillator leads providing "integrated bipolar" sensing. The vast majority of nonadequate arrhythmia detection were observed during intrinsic bradycardia heart rate and/or antibradycardia pacing. Electrical lead failure was ruled out in every patient. In 90% of the patients with a cardioverter-defibrillator providing programmable maximal sensitivity (n=16), the reduction of maximum sensitivity was effective in preventing further episodes of nonadequate arrhythmia detection. In 48% of the patients with devices without programmable maximal sensitivity (n=17), surgery revision was necessary to solve the problem.